We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Global X ETFs Global X Telemedicine & Digital Health UCITS ETF (EDOC)

Sell:$8.02 Buy:$8.07 0 Change: $0.021 (0.26%)
Market closed |  Prices as at close on 27 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$8.02
Buy:$8.07
Change: $0.021 (0.26%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 27 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$8.02
Buy:$8.07
Change: $0.021 (0.26%)
Market closed |  Prices as at close on 27 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

REPLICATION

Replication method: Stocks - Full Replication
Rebalancing frequency: Biannually
Number of holdings: 40
How is collateral used? Physical replication

SECURITIES LENDING

Is stock lending permitted?: Yes
Is stock currently being lent?: No
Maximum that can be lent: n/a
12 month average % on loan: n/a
12 month return from stock lending: n/a
Gross revenue returned: n/a

COUNTERPARTIES

Issuer: Global X ETFs ICAV
Investment Manager: n/a
Trustee SEI Investments Trustee and Custodial Services (Ireland) Limited
Custodian: Brown Brothers Harriman
Security Weight
MEDLEY INC 42.34%
ALIBABA HEALTH INFORMATION TECH LTD 13.85%
JD HEALTH INTL INC 12.90%
PING AN HEALTHCARE & TECHNO CO LTD 4.86%
RESMED INC 1.69%
MASIMO CORP 1.63%
DOXIMITY INC 1.55%
DEXCOM 1.44%
AGILENT TECHNOLOGIES INC 1.23%
LABORATORY CORP OF AMERICA HLDGS 1.19%

ASSET SPLIT

Annual & interim reports

Before you invest, please make sure you read the documents below

OBJECTIVE

Index: The Index aims to provide exposure to exchange-listed companies that are positioned to benefit from advances and application of advances in the field of telemedicine and digital health (collectively “Telemedicine & Digital Health Companies”). A company must derive at least 50% of its revenue, operating income, or assets from telemedicine and/or digital health to be considered for inclusion in the Index. Telemedicine and Digital Health Companies include those involved in the following business activities (i) telemedicine, (ii) healthcare analytics, (iii) connected healthcare devices and/or (iv) administrative digitisation.
Aim: The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to invest in...
Read full aim for Global X ETFs
Leverage: 100%
Currency hedging: n/a

COSTS

Ongoing Charge (OCF/TER): 0.68%
Management fee: 0.68%
Indicative spread: 0.71%

In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.

Company announcements

No company announcements about Global X ETFs Global X Telemedicine & Digital Health UCITS ETF were found.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data provided by Broadridge. Some of the data on this page and other related pages is provided to you for your information and is received from the Fund Management Company administering this fund. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties. Securities lending data correct as at date not available. Charge data correct as at date not available. Holdings correct as at 21 March 2023. News service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2024. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.